Last update 01 Nov 2024

Ruxotemitide

Overview

Basic Info

Drug Type
Synthetic peptide
Synonyms
Cancer-vaccine-Lytix-Biopharma, Oncopore, LTX-315
+ [2]
Mechanism
Mitochondrial proteins inhibitors
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Structure

Molecular FormulaC78H106N18O9
InChIKeyGGAKLYWEFZCVIT-TVEKFXMRSA-N
CAS Registry1345407-05-7

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Basal Cell CarcinomaPhase 2
US
01 Feb 2022
Skin NeoplasmsPhase 2
US
01 Feb 2022
MelanomaPhase 2
US
01 Jun 2021
MelanomaPhase 2
FR
01 Jun 2021
MelanomaPhase 2
NO
01 Jun 2021
MelanomaPhase 2
ES
01 Jun 2021
Metastatic Soft Tissue SarcomaPhase 2
DK
28 Dec 2018
SarcomaPhase 2--
Head and Neck NeoplasmsPhase 1
BE
01 Nov 2013
Head and Neck NeoplasmsPhase 1
FR
01 Nov 2013
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
Metastatic Soft Tissue Sarcoma
tumor-infiltrating lymphocytes | neoantigens
6
xcvufxjriq(osctvakplj) = only expected and manageable toxicity uxjtcgkedy (zbbonvfxxp )
Positive
31 Dec 2024
Phase 2
93
iotdptevna(qzaexkcreo) = sfzbuxqsip wriupmkaod (fahfruauhk )
Positive
14 Aug 2024
Phase 2
6
zvvdvmvpzn(fhrqunlvvq) = xsaoppakam pcnushtzex (owcffhbvmk, ectkmhavpm - bgtgkjcoqu)
-
08 Nov 2023
Phase 2
14
LTX-315+pembrolizumab
ubjwrgnysb(jfwpkwtajg) = ztkrexsvaa cnlpwhtiwl (yjnfprgxqh )
Positive
23 Oct 2023
Phase 2
6
dorjvhgbyu(sgpwrspscd) = pwjxvckhbp fvnbbawdsb (rbgkuqighb )
Positive
02 Jun 2022
Phase 1
-
dfdjfrdbgz(dndctkiamx) = ebhanuyvuw ohjzeoczct (xausnipcvd )
-
04 Feb 2021
Phase 1
27
tixxcrrsuj(zlciujudcb) = None luybyjhadn (bxffsknhjx )
Positive
01 Jul 2019
Phase 1/2
59
xeaztvefar(ozwymzxblo) = ygxqfehunr mpxtznpeht (byjwxvhxca )
Positive
04 Jun 2018
ibyxninssf(iznoidzalk) = kokaorunxa dbcovapvqz (uaqxnkisxw )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free